Delivery Order SPE2DB20D1100-SPE2DB24FZ84F

Award Date 1/22/24
Potential Completion Date 2/12/24
Potential Value $21K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of global pharmaceutical distributor Amerisourcebergen Corporation. The $21,163.20 delivery order is for GEL-ONE 30 MG/3 ML SYRINGE 3ML, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This $5,290.80 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of February 26, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this order is $5,290.80, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not designated as a set-aside contract. This award is part of...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563308866 - GEL-ONE 30 MG/3 ML SYRINGE 3ML. The order has a potential value of $19,752.32 and a completion date of January 24, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received multiple awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and distribution services...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this contract is $1,763.60 and the completion date is March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense, through indefinite delivery...
This is a $3,649 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corporation by the Defense Logistics Agency (DLA) for the provision of GEL-ONE 30 MG/3 ML syringes. The order has an ultimate completion date of December 24, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $21,163.20 contract is to provide GEL-ONE 30 MG/3 ML syringes for DLA Troop Support Medical. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical products. The $110,400.00 delivery order has a completion date of February 28, 2022 and was awarded on February 4, 2022. Amerisourcebergen Drug Corp, a For Profit Organization with its Corporate Office division, has a history of providing pharmaceutical and medical supply...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract has a potential value of $21,163.20 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to DLA's...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,527.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FZ84F
    Delivery Order

This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $21,163.20 order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceuticals to support DLA Troop Support Medical facilities. This is one of many such delivery orders Amerisourcebergen Drug Corp has received from DLA to provide pharmaceuticals and medical supplies, as the company holds an Indefinite Delivery Indefinite Quantity (IDIQ) contract with the agency. No set-aside designation was used for this award, which will be performed at Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania. The period of performance runs through February 12, 2024.

Generated 4/22/24, 9:04 AM